Xylem (NYSE:XYL – Get Free Report) had its target price lowered by Royal Bank Of Canada from $164.00 to $135.00 in a research report issued to clients and investors on Wednesday, Benzinga reports. The brokerage presently has an “outperform” rating on the industrial products company’s stock. Royal Bank Of Canada’s price objective would suggest a potential upside of 30.97% from the stock’s previous close.
Other equities analysts have also recently issued reports about the company. Stifel Nicolaus upped their price objective on Xylem from $157.00 to $160.00 and gave the company a “buy” rating in a research report on Wednesday, July 29th. Barclays cut their target price on Xylem from $159.00 to $139.00 and set an “overweight” rating on the stock in a research note on Tuesday. Mizuho lifted their target price on Xylem from $124.00 to $130.00 and gave the stock a “neutral” rating in a report on Wednesday, July 29th. CLSA upgraded Xylem to a “hold” rating in a research note on Thursday, June 25th. Finally, Wolfe Research started coverage on Xylem in a research note on Tuesday, September 15th. They issued a “peer perform” rating for the company. Nine equities research analysts have rated the stock with a Buy rating and seven have issued a Hold rating to the company. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $147.69.
View Our Latest Research Report on XYL
Xylem Stock Up 0.5%
Xylem (NYSE:XYL – Get Free Report) last released its quarterly earnings data on Tuesday, July 28th. The industrial products company reported $1.46 earnings per share for the quarter, beating analysts’ consensus estimates of $1.34 by $0.12. Xylem had a net margin of 11.15% and a return on equity of 11.77%. The business had revenue of $2.34 billion during the quarter, compared to analyst estimates of $2.34 billion. Xylem’s revenue was up 1.5% compared to the same quarter last year. During the same period last year, the business earned $1.26 EPS. Xylem has set its FY 2026 guidance at 5.550-5.700 EPS. On average, sell-side analysts anticipate that Xylem will post 5.66 EPS for the current year.
Institutional Trading of Xylem
Hedge funds and other institutional investors have recently added to or reduced their stakes in the business. XXEC Inc. purchased a new position in Xylem in the 2nd quarter worth approximately $850,841,000. J. Stern & Co. LLP grew its holdings in Xylem by 12,326.6% during the 4th quarter. J. Stern & Co. LLP now owns 45,448,168 shares of the industrial products company’s stock valued at $6,189,132,000 after buying an additional 45,082,435 shares in the last quarter. BlackRock Inc. purchased a new stake in Xylem during the 2nd quarter valued at approximately $2,959,730,000. Bank of New York Mellon Corp purchased a new stake in Xylem during the 2nd quarter valued at approximately $552,313,000. Finally, Hsbc Holdings PLC bought a new stake in shares of Xylem during the second quarter valued at approximately $319,785,000. 87.96% of the stock is owned by hedge funds and other institutional investors.
Xylem Company Profile
Xylem Inc (NYSE: XYL) is a global water technology company that develops products, services and solutions for the movement, treatment, testing and efficient use of water. Its offerings serve municipal water and wastewater systems, utilities, industrial customers, commercial buildings and other infrastructure operators.
The company’s portfolio includes water and wastewater pumps, mixing and aeration equipment, treatment systems, measurement and monitoring technologies, smart metering, network-management software, and related services.
See Also
- Five stocks we like better than Xylem
- Quantum BioPharma’s Phase 2 Shows Where Biotech Value Actually Gets Built
- Albertsons Is Betting on a Turnaround—But Will It Pay Off?
- Venezuela’s Oil Revival Is Gaining Momentum—3 Energy Stocks Positioned to Benefit
- PepsiCo’s Earnings Beat Masks a Bigger Problem With Its North American Business
Receive News & Ratings for Xylem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Xylem and related companies with MarketBeat.com's FREE daily email newsletter.
